RIPK1 and myocardial infarction: Inspired by a landmark study published by Degterev et al. showing that Nec-1 could decrease infarct size after middle cerebral artery occlusion [32], Smith et al. investigated the role of RIPK1 in MI and the efficacy of Nec-1 in decreasing MI severity.